Koichi Yoshida

发表

Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection

J. Usuda, H. Honda, T. Ohira, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma.

H. Kato, T. Ohira, T. Hirano, 2003, Lung cancer.

Prognostic Impact of Number of Resected and Involved Lymph Nodes at Complete Resection on Survival in Non-small Cell Lung Cancer

J. Usuda, T. Ohira, M. Tsuboi, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014–2015†

H. Miyata, S. Toyooka, M. Okada, 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan

M. Tsuboi, Koichi Yoshida, Y. Ohashi, 2018, Japanese journal of clinical oncology.

A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.

J. Usuda, T. Ohira, M. Tsuboi, 2013, Chest.

Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.

T. Ohira, Y. Shimada, H. Saji, 2015, Clinical lung cancer.

Diagnosis and Treatment of Multiple Primary Lung Cancers

H. Tsutsui, T. Ohira, Koichi Yoshida, 2014 .

Development of an annually updated Japanese national clinical database for chest surgery in 2014

H. Miyata, S. Toyooka, Koichi Yoshida, 2016, General Thoracic and Cardiovascular Surgery.

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

T. Ohira, Koichi Yoshida, N. Ikeda, 2013, Cellular Oncology.

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

T. Ohira, M. Tsuboi, Koichi Yoshida, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer

Koichi Yoshida, F. Hirsch, M. Wynes, 2009, Therapeutic advances in medical oncology.

Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.

H. Kato, T. Ohira, M. Tsuboi, 2005, Lung cancer.

Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer

T. Ohira, Koichi Yoshida, M. Kakihana, 2016, Cancer science.

Comparison of the Computed Tomography Findings by the positive or negative of Epidermal Growth Factor Receptor (EGFR) mutation of primary lung cancer

T. Ohira, Koichi Yoshida, S. Akata, 2012 .

Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer.

J. Usuda, H. Honda, T. Ohira, 2013, Chest.

EGFR Protein Expression in Non–Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor—A Novel Antibody for Immunohistochemistry or AQUA Technology

Cindy Tran, Toshitaka Nagao, Norihiko Ikeda, 2011, Clinical Cancer Research.

Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II–III

T. Ohira, T. Okano, Koichi Yoshida, 2019, Oncology letters.

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification

T. Ohira, Y. Shimada, H. Saji, 2013, OncoTargets and therapy.

The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.

T. Ohira, Y. Shimada, H. Saji, 2016, Chest.

Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.

T. Ohira, Y. Shimada, H. Saji, 2015, Lung cancer.

[Traumatic Lung Injury].

Koichi Yoshida, N. Ikeda, S. Ichinose, 2015, Kyobu geka. The Japanese journal of thoracic surgery.

IGF-1R as a predictive marker for EGFR TKI (Gefitinib) resistance in Non Small Cell Lung Cancer using IHC and AQUA technology

T. Ohira, Koichi Yoshida, N. Ikeda, 2011 .

Skin fluorescence following photodynamic therapy with NPe6 photosensitizer.

J. Usuda, T. Ohira, Koichi Yoshida, 2017, Photodiagnosis and photodynamic therapy.

Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence.

J. Usuda, T. Ohira, M. Tsuboi, 2013, Oncology reports.

Early experience using the da Vinci Surgical System for the treatment of mediastinal tumors

J. Usuda, T. Ohira, Koichi Yoshida, 2011, General thoracic and cardiovascular surgery.

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

T. Ohira, M. Tsuboi, Koichi Yoshida, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

H. Kato, T. Ohira, T. Hirano, 2001, British Journal of Cancer.

High-speed 3-dimensional imaging in robot-assisted thoracic surgical procedures.

T. Ohira, Koichi Yoshida, M. Kakihana, 2014, The Annals of thoracic surgery.

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

T. Ohira, Koichi Yoshida, N. Ikeda, 2013, Cellular Oncology.

Maximizing use of robot-arm no. 3 in daVinci-assisted thoracic surgery.

T. Ohira, Koichi Yoshida, M. Kakihana, 2015, International surgery.